Source:http://linkedlifedata.com/resource/pubmed/id/19699593
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2009-9-14
|
pubmed:abstractText |
The present study investigated the potential efficacy of buspirone for treating marijuana dependence. Participants received either buspirone (maximum 60mg/day) (n=23) or matching placebo (n=27) for 12 weeks, each in conjunction with motivational interviewing. In the modified intention-to-treat analysis, the percentage of negative UDS results in the buspirone-treatment group was 18 percentage points higher than the placebo-treatment group (95% CI: -2% to 37%, p=0.071). On self-report, participants receiving buspirone reported not using marijuana 45.2% of days and participants receiving placebo reported not using 51.4% of days (p=0.55). An analysis of participants that completed the 12-week trial showed a significant difference in the percentage negative UDS (95% CI: 7-63%, p=0.014) and a trend for participants randomized to the buspirone-treatment group who completed treatment to achieve the first negative UDS result sooner than those participants treated with placebo (p=0.054). Further study with buspirone in this population may be warranted; however, strategies to enhance study retention and improve outcome measurement should be considered in future trials.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1879-0046
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
105
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
132-8
|
pubmed:dateRevised |
2011-9-26
|
pubmed:meshHeading |
pubmed-meshheading:19699593-Adult,
pubmed-meshheading:19699593-Anti-Anxiety Agents,
pubmed-meshheading:19699593-Anxiety,
pubmed-meshheading:19699593-Buspirone,
pubmed-meshheading:19699593-Cannabinoids,
pubmed-meshheading:19699593-Cannabis,
pubmed-meshheading:19699593-Double-Blind Method,
pubmed-meshheading:19699593-Female,
pubmed-meshheading:19699593-Humans,
pubmed-meshheading:19699593-Male,
pubmed-meshheading:19699593-Marijuana Abuse,
pubmed-meshheading:19699593-Motivation,
pubmed-meshheading:19699593-Psychiatric Status Rating Scales,
pubmed-meshheading:19699593-Questionnaires,
pubmed-meshheading:19699593-Sample Size,
pubmed-meshheading:19699593-Substance Withdrawal Syndrome,
pubmed-meshheading:19699593-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
A placebo-controlled trial of buspirone for the treatment of marijuana dependence.
|
pubmed:affiliation |
Department of Psychiatry, Medical University of South Carolina, 67 President Street, Charleston, SC 29425, USA. mcraeal@musc.edu
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, N.I.H., Extramural
|